Delivery Order SPE2DB22D9367-SPE2DB25FSZ72
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 12, 2025, for the supply of Jakafi 10 mg tablets (60-count). This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 13, 2025. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Jakafi 15 mg tablets (60-count units) with a ceiling value of $11,999.80. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and was awarded on August 1, 2025. This award utilizes no set-aside designation, allowing DMS Pharmaceutical Group to...
- The U.S. Department of Defense Medical Supply Chain awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $36,346.95 for Jakafi 10 mg tablets (60-count units). Issued on September 2, 2025, with an ultimate completion date of September 3, 2025, this firm fixed-price delivery order carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12.0K on July 22, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), the Department of Defense's combat support agency responsible for logistics and supply chain management. The award carries an ultimate completion date of July 23, 2025, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on July 23, 2025, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,146.79 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and was awarded without set-aside designation. This delivery order is issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,146.79 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Jakafi 5 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its established...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $72,880.74 on August 11, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The award was issued under a firm fixed-price contract with no set-aside designation and is set for ultimate completion by August 12, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on July 21, 2025, for the supply of Jakafi 10 mg tablets (60-count packages). The contract utilizes a firm fixed-price structure with no set-aside designation and carries an ultimate completion date of July 22, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,293.60 on July 28, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The contract, which carries no set-aside designation, is issued under DMS's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million through November 2026. This delivery order will be...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ72Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,999.80 by the Defense Logistics Agency on September 11, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a continuation of the company's substantial pharmaceutical supply relationship with the Department of Defense. The award was made without a set-aside designation, demonstrating the contractor's competitive standing in the federal procurement marketplace. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending through November 2026. The underlying contract authorizes the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, over-the-counter drugs, and medical consumables to support military healthcare facilities. Jakafi, a prescription medication used in the treatment of myelofibrosis and polycythemia vera, reflects the contractor's established role in supplying specialized pharmaceutical products critical to the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 9/11/25 |